SCHEMBL13428341

SCHEMBL13428341

c1ccc2c(c1)Cc1ccccc1N2c1cccc2c(-c3cccc4ccccc34)c3c(N4c5ccccc5Cc5ccccc54)cccc3c(-c3cccc4ccccc34)c12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.41
TSHR P16473 2/20 0.35
CYP3A4 P08684 1/20 0.35
HPGD P15428 4/20 0.35
HTR1A P08908 9/20 0.34
HTR7 P34969 7/20 0.34
HSD17B10 Q99714 2/20 0.34
CYP1A2 P05177 2/20 0.34
CYP2D6 P10635 2/20 0.34
HTR3E A5X5Y0 1/20 0.34
HTR3B O95264 1/20 0.34
NCF1 P14598 1/20 0.34
NFKB1 P19838 1/20 0.34
HTR1D P28221 1/20 0.34
HTR1B P28222 1/20 0.34
HTR2A P28223 1/20 0.34
MTOR P42345 1/20 0.34
HTR3A P46098 1/20 0.34
HTR5A P47898 1/20 0.34
HTR6 P50406 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10941014 0.80 POLB (0.52) POLBTSHRCYP3A4HPGDHTR1A
SCHEMBL13008476 0.80 POLB (0.42) POLBCYP3A4HPGDHSD17B10CYP1A2
SCHEMBL13428337 0.80 HPGD (0.41) POLBTSHRCYP3A4HPGDHTR1A
SCHEMBL13428362 0.79 BCHE (0.45) POLBCYP3A4HPGDHSD17B10CYP1A2
SCHEMBL13428344 0.79 POLB (0.41) POLBTSHRHPGDHSD17B10NFKB1
SCHEMBL13428333 0.78 CYP3A4 (0.36) TSHRCYP3A4HPGDCYP1A2PDE6D
SCHEMBL13426910 0.77 POLB (0.38) POLBTSHRCYP3A4HPGDHTR1A
SCHEMBL13008471 0.77 KMT2A (0.44) POLBHPGDHSD17B10CYP1A2CYP2D6
SCHEMBL13008231 0.74 POLB (0.35) POLBHPGDHTR1AHTR7
SCHEMBL13008245 0.72 POLB (0.34) POLBTSHRHPGDHTR1AHTR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-03-04 US disclosed
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same RPL36, RPL39, RPL36A POLB 913/4885TSHR 3567/4885CYP3A4 2263/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.